These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 7702277

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
    Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, Brown J, Fischer D, Bolognia J, Buzaid AC.
    Cancer; 1999 Dec 01; 86(11):2252-8. PubMed ID: 10590365
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
    Francken AB, Accortt NA, Shaw HM, Wiener M, Soong SJ, Hoekstra HJ, Thompson JF.
    Ann Surg Oncol; 2008 May 01; 15(5):1476-84. PubMed ID: 18196345
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma.
    Noorda EM, Takkenberg B, Vrouenraets BC, Nieweg OE, van Geel BN, Eggermont AM, Hart GA, Kroon BB.
    Ann Surg Oncol; 2004 May 01; 11(5):491-9. PubMed ID: 15078633
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ultra-late recurrence (15 years or longer) of cutaneous melanoma.
    Tsao H, Cosimi AB, Sober AJ.
    Cancer; 1997 Jun 15; 79(12):2361-70. PubMed ID: 9191524
    [Abstract] [Full Text] [Related]

  • 11. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
    Shields CL.
    Trans Am Ophthalmol Soc; 2000 Jun 15; 98():471-92. PubMed ID: 11190037
    [Abstract] [Full Text] [Related]

  • 12. [Ultra-late metastasis of melanoma with secondary dissemination along the venous stripping line].
    Nicolas C, Reichert-Penetrat S, Granel F, Barbaud A, Schmutz JL.
    Ann Dermatol Venereol; 2000 Jan 15; 127(1):60-3. PubMed ID: 10717565
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.
    Dalal KM, Patel A, Brady MS, Jaques DP, Coit DG.
    Ann Surg Oncol; 2007 Jun 15; 14(6):1934-42. PubMed ID: 17406951
    [Abstract] [Full Text] [Related]

  • 15. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB, Lee RJ, Prescott RJ, Doherty VR.
    Br J Dermatol; 2004 Mar 15; 150(3):523-30. PubMed ID: 15030337
    [Abstract] [Full Text] [Related]

  • 16. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma.
    Posther KE, Selim MA, Mosca PJ, Stanley WE, Johnson JL, Tyler DS, Seigler HF.
    Ann Surg Oncol; 2006 May 15; 13(5):728-39. PubMed ID: 16538415
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing tumour relapse after total laryngectomy.
    Nikolaou A, Markou K, Petridis D, Vlachtsis K, Nalbantian M, Daniilidis L.
    B-ENT; 2005 May 15; 1(1):1-10. PubMed ID: 15999669
    [Abstract] [Full Text] [Related]

  • 18. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick).
    Khayat D, Rixe O, Martin G, Soubrane C, Banzet M, Bazex JA, Lauret P, Vérola O, Auclerc G, Harper P, Banzet P, French Group of Research on Malignant Melanoma.
    Cancer; 2003 Apr 15; 97(8):1941-6. PubMed ID: 12673721
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Significant survival advantage in 96 treated patients in comparison with 288 untreated symptomatic controls].
    Beiteke U, Ruppert P, Garbe C, Oxenfarth R, Kastl I, Türker T, Tronnier H, Frosch PJ.
    Hautarzt; 1993 Jun 15; 44(6):365-71. PubMed ID: 8335459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.